Novo Nordisk shares slide after 2030 strategic ambitions
Novo Nordisk (NVO) shares fell about 5.96% in Copenhagen trading after the company used its London Capital Markets Day to outline 2030 strategic ambitions under new CEO Mike Doustdar.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.